The outcomes of conservatively observed asymptomatic nonfunctioning pituitary adenomas with optic nerve compression

被引:5
作者
Hwang, Kihwan [1 ]
Kim, Yong Hwy [3 ]
Kim, Jung Hee [4 ]
Lee, Jung Hyun [4 ]
Yang, Hee Kyung [2 ]
Hwang, Jeong-Min [2 ]
Kim, Chae-Yong [1 ]
Han, Jung Ho [1 ]
机构
[1] Seoul Natl Univ, Bundang Hosp, Dept Neurosurg, Seongnam Si, South Korea
[2] Seoul Natl Univ, Bundang Hosp, Dept Ophthalmol, Seongnam Si, South Korea
[3] Seoul Natl Univ Hosp, Dept Neurosurg, Seoul, South Korea
[4] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
pituitary adenoma; nonfunctioning; optic nerve; observation; natural history; pituitary surgery; MANAGEMENT;
D O I
10.3171/2020.4.JNS192778
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE The authors investigated the natural history of asymptomatic nonfunctioning pituitary adenomas (NFPAs) with optic nerve compression. METHODS This study retrospectively analyzed the natural history of asymptomatic NFPAs with documented optic nerve compression on MRI diagnosed between 2000 and 2016 from 2 institutions. The patients were followed up with regular endocrinological, ophthalmological, and radiological evaluations, and the endpoint was new endocrinopathy or neurological deficits. RESULTS The study comprised 81 patients. The median age at diagnosis was 58.0 years and the follow-up duration was 60.0 months. As the denominator of overall pituitary patients, 2604 patients were treated with surgery after diagnosis at the 2 institutions during the same period. The mean initial and last measured values for tumor diameter were 23.7 +/- 8.9 mm and 26.2 +/- 11.4 mm, respectively (mean +/- SD). Tumor growth was observed in 51 (63.0%) patients; however, visual deterioration was observed in 14 (17.3%) patients. Ten (12.3%) patients experienced endocrine deterioration. Fourteen (17.3%) patients underwent surgery for either visual deterioration (in 12 patients) or endocrine dysfunction (in 2 patients). After surgery, all patients experienced improvements in visual or hormonal function. The actuarial rates of treatment-free survival at 2, 3, and 5 years were 96.1%, 93.2%, and 85.6%, respectively. In the multivariate analysis, initial cavernous sinus invasion (HR 4.985, 95% CI 1.597-15.56; p = 0.006) was the only independent risk factor for eventual treatment. CONCLUSIONS The neuroendocrinological deteriorations were not frequent and could be recovered by surgery with early detection on regular follow-up in asymptomatic NFPAs with documented optic nerve compression on MRI. There-fore, conservative management could be an acceptable strategy for these tumors. Careful follow-up is required for tumors with cavernous sinus invasion.
引用
收藏
页码:1808 / 1815
页数:8
相关论文
共 14 条
  • [1] Neuro-ophthalmologic exploration in non-functioning pituitary adenoma
    Abouaf, Lucie
    Vighetto, Alain
    Lebas, Maud
    [J]. ANNALES D ENDOCRINOLOGIE, 2015, 76 (03) : 210 - 219
  • [2] Management of pituitary incidentaloma
    Boguszewski, Cesar Luiz
    de Castro Musolino, Nina Rosa
    Kasuki, Leandro
    [J]. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 33 (02)
  • [3] Non-functioning pituitary adenoma: When and how to operate? What pathologic criteria for typing?
    Castinetti, Frederic
    Dufour, Henry
    Gaillard, Stephane
    Jouanneau, Emmanuel
    Vasiljevic, Alexandre
    Villa, Chiara
    Trouillas, Jacqueline
    [J]. ANNALES D ENDOCRINOLOGIE, 2015, 76 (03) : 220 - 227
  • [4] Treatment and follow-up of clinically nonfunctioning pituitary macroadenomas
    Dekkers, O. M.
    Pereira, A. M.
    Romijn, J. A.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (10) : 3717 - 3726
  • [5] The natural course of non-functioning pituitary macroadenomas
    Dekkers, O. M.
    Hammer, S.
    de Keizer, R. J. W.
    Roelfsema, F.
    Schutte, P. J.
    Smit, J. W. A.
    Romijn, J. A.
    Pereira, A. M.
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2007, 156 (02) : 217 - 224
  • [6] Dho Yun-Sik, 2017, Brain Tumor Res Treat, V5, P16, DOI 10.14791/btrt.2017.5.1.16
  • [7] Management of nonfunctioning pituitary incidentaloma
    Galland, Francoise
    Vantyghem, Marie-Christine
    Cazabat, Laure
    Boulin, Anne
    Cotton, Francois
    Bonneville, Jean-Francois
    Jouanneau, Emmanuel
    Vidal-Trecan, Gwenaelle
    Chanson, Philippe
    [J]. ANNALES D ENDOCRINOLOGIE, 2015, 76 (03) : 191 - 200
  • [8] Management of nonfunctioning pituitary adenomas (NFAs): observation
    Huang, Wenyu
    Molitch, Mark E.
    [J]. PITUITARY, 2018, 21 (02) : 162 - 167
  • [9] Growth Pattern and Prognostic Factors of Untreated Nonfunctioning Pituitary Adenomas
    Hwang, Kihwan
    Kwon, Taehun
    Park, Jay
    Joo, Jin-Deok
    Han, Jung Ho
    Oh, Chang Wan
    Kim, Chae-Yong
    [J]. JOURNAL OF KOREAN NEUROSURGICAL SOCIETY, 2019, 62 (02) : 256 - 262
  • [10] Predicting Visual Outcome After Treatment of Pituitary Adenomas With Optical Coherence Tomography
    Jacob, Maud
    Raverot, Gerald
    Jouanneau, Emmanuel
    Borson-Chazot, Francoise
    Perrin, Gilles
    Rabilloud, Muriel
    Tilikete, Caroline
    Bernard, Martine
    Vighetto, Alain
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2009, 147 (01) : 64 - 70